Integra LifeSciences Provides Preliminary Q3 Results and Cuts Full-Year 2026 Guidance
Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced preliminary third-quarter results and updated its full-year 2026 guidance. The company cited the ongoing impact of a July flooding event at its Cincinnati facility as the reason for the revised outlook.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.